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Fecal short chain fatty acids 
in children living on farms and a link 
between valeric acid and protection 
from eczema
Monica Gio‑Batta1*, Fei Sjöberg1, Karin Jonsson2, Malin Barman2,3, Anna‑Carin Lundell4, 
Ingegerd Adlerberth1, Bill Hesselmar5, Ann‑Sofie Sandberg2 & Agnes E. Wold1
Children growing up on farms have low rates of allergy, but the mechanism for this protective effect 
has not been fully elucidated. Short chain fatty acids (SCFAs) produced by the gut microbiota may play 
a role in protection from allergy. We measured fecal SCFA levels in samples collected from 28 farming 
and 37 control children over the first 3 years of life using gas chromatography. Data on diet and other 
host factors were recorded and allergy was diagnosed at 8 years of age. Among all children, median 
propionic and butyric acid concentration increased over the first 3 years, and longer SCFAs typically 
appeared by 1 year of age. Farm children had higher levels of iso‑butyric, iso‑valeric and valeric acid 
at 3 years of age than rural controls. In addition, children with elder siblings had higher levels of 
valeric acid at 3 years of age, and dietary factors also affected SCFA pattern. High levels of valeric acid 
at 3 years of age were associated with low rate of eczema at 8 years of age. The fecal SCFA pattern 
in farm children suggests a more rapid maturation of the gut microbiota. Valeric acid or associated 
microbes may have protective potential against eczema.
Living on a farm is protective against immunoregulatory and inflammatory diseases, including allergic  diseases1,2 
and inflammatory bowel disease (IBD)3. Farmers also have reduced rates of colorectal and other  cancers4. The 
prevalence of allergy and IBD has increased dramatically over the last century in industrialized  countries5,6, while 
rates in farming families have remained low by  comparison1,3. Which exposures in the farming environment 
that exert the protective effect is unknown, but exposure to a wider range of microbes during  infancy7, or typical 
dietary patterns in farming  families8 may contribute.
Short chain fatty acids (SCFAs) are the most abundant bacterial metabolites in the colon and have been pro-
posed as key mediators in microbiota-induced effects on the  host9. They contain between two and six carbon 
atoms, and are produced when dietary fibre and protein, mucous and sloughed epithelial cells are metabolized by 
gut bacteria. The major SCFAs generated in the colon are short unbranched varieties such as acetic, propionic and 
butyric acid. As the microbiota becomes more complex, longer SCFAs, such as valeric acid, are produced. Further, 
the branched SCFAs, iso-butyric and iso-valeric acid, appear. These are generated by the bacterial metabolism 
of  protein10. Iso-caproic acid is a branched SCFA considered a marker of colonization by Clostridium difficile11, 
an obligate anaerobe that is fairly common in the gut microbiota of young  children12.
Many SCFAs exhibit effects that could play a role in immunoregulatory and inflammatory diseases. Within 
the gut, SCFAs maintain epithelial barrier function by decreasing intestinal tight junction  permeability13 and 
inducing secretion of the epithelium’s protective mucous  layer14. Butyric acid is the major source of energy for 
 colonocytes15 and is also a histone deacetylase inhibitor, making it important in the control of gene  expression16. 
While butyrate is almost fully consumed in the colon, acetic and propionic acids can be detected in periph-
eral blood, where they may elicit physiological effects in various body  tissues9,17, e.g. via activation of G-pro-
tein coupled receptors, found on the surface of many different cell  types9. Very little is known regarding the 
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immunomodulatory effects of longer and branched SCFAs. However, in a birth cohort study, higher levels of 
iso-butyric, valeric and iso-valeric acid at 1 year of age were inversely related to the development of food allergy 
by age  four18.
The aim of this study was to investigate whether children growing up on small dairy farms had an altered 
fecal SCFA pattern compared to children living in the same rural area but not on farms, and if so to investigate 
whether this pattern was related to subsequent allergy outcomes. A secondary aim was to describe the develop-
ment in fecal SCFA pattern over the first 3 years of life.
Methods
Subjects. The FARMFLORA birth cohort comprised 28 infants raised on small family-owned dairy farms 
in Skaraborg County in South-West Sweden and 37 infants from the same rural area but not raised on farms 
who were followed until 8 years of age. Pregnant women were recruited between September 2005 and May 2008. 
Healthy children born at term were included, and subjects from dairy farms with infrequent animal contact, 
from non-dairy farms, or from urban areas were excluded. The study conforms to the standards of the Decla-
ration of Helsinki and was approved by the Regional Ethics Committee in Gothenburg (No. 363-05). Written 
informed consent was obtained from the parents of all participants.
The cohort characteristics are shown in Table 1. There were fewer boys in the farm group than in the rural 
control group (36% vs. 62%, P = 0.04), and farm children more often had a cat or dog (75% vs. 51%, P = 0.054). 
Farm children consumed more full-fat milk products and less margarine and oils compared with the rural control 
children, as reported  previously8,19. At 1 year of age, farm children also consumed more oily fish (P = 0.02) and 
farm milk (P < 0.01), while control children consumed more poultry (P = 0.03)8,19.
Table 1.  General and nutritional characteristics of farm and control children. Data are n (%) or median 
(range). *P < 0.05, Chi-squared or Fisher’s exact test for counts, Mann–Whitney U-test for continuous 
variables. a Doctor-diagnosed asthma, rhinitis, or atopic eczema. b 1 = Elementary school, 2 = upper secondary 
school 2–3 years or equivalent, 3 = qualified graduate from upper secondary school, 4 = university < 1 year, 
5 = university > 1 year. c During the last month of pregnancy. d At the time of recruitment. e Doctor-diagnosed 
asthma, atopic eczema, allergic rhino-conjunctivitis or food allergy. At 3 years, n = 27 farm children and 36 
rural controls; at 8 years, n = 18 farm children and 30 rural controls. f Pasteurized and unpasteurized. Data 
selected from a previous study on the FARMFLORA birth  cohort8, with intake of milk fats calculated here.
Farm (n = 28) Control (n = 37) P
Family
Allergic heredity,  mothera 7 (25%) 11 (30%) 0.68
Allergic heredity,  fathera 1 (4%) 12 (32%) 0.01*
Level of education,  motherb 2 (1–5) 4 (1–5) 0.20
Level of education,  fatherb 2 (1–5) 2 (1–5) 0.02*
Smoking,  motherc 0 (0%) 1 (3%) 1.00
Smoking,  fatherc 1 (4%) 4 (11%) 0.38
Elder sibling(s) 18 (64%) 17 (46%) 0.15
Cat or dog in  housed 21 (75%) 19 (51%) 0.05
Birth and child
Mother’s age at delivery (years) 33 (21–42) 32 (22–41) 0.46
Caesarian section 3 (11%) 7 (19%) 0.50
Male 10 (36%) 23 (62%) 0.04*
Allergic at 3 yearse 1 (4%) 10 (32%) 0.02*
Allergic at 8 yearse 3 (11%) 7 (19%) 0.72
Breastfeeding and child’s diet at 1 year
Exclusive breastfeeding (months) 4.0 (0.0–6.0) 3.5 (0.0–6.0) 0.11
Fat (g/day) 33 (7–78) 32 (14–62) 0.70
Margarine and oil (g/day) 3 (0–19) 5 (0–26) 0.10
Cream (g/day) 1 (0–28) 0 (0–14) 0.02*
Milk fats (g/day) 11 (0–35) 5 (0–29) 0.04*
Oily fish (g/day) 0 (0–63) 0 (0–15) 0.02*
Protein (g/day) 35 (5–60) 34 (19–62) 0.69
Poultry (g/day) 0 (0–5) 0 (0–75) 0.03*
Carbohydrates (g/day) 130 (23–183) 135 (65–194) 0.11
Fibre (g/day) 11 (2–18) 11 (4–18) 0.93
Fruit and vegetables (g/day) 150 (77–200) 180 (90–240) 0.22
Farm milk (g/day)f 0(0–343) 0 (0–0) < 0.01*
Homemade porridge (g/day) 0 (0–175) 0 (0–100) 0.06
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Clinical examination. Children in the FARMFLORA study were examined by study pediatricians to 
diagnose eczema, asthma, allergic rhino-conjunctivitis and food allergy according to predefined protocols at 
18 months, 3 years and 8 years of age. All diagnoses were confirmed by a specialist pediatric allergologist (BH). 
As described previously, living on a farm was associated with protection from allergy at 3 years of  age8, but by 
8 years of age there was no such  association20. In brief, at 8 years of age, eczema was diagnosed according to 
William’s criteria, or as having recurring itchy spots on typical locations over at least 6 months, with symp-
toms during the last 12  months. Asthma was diagnosed based on wheeze or heavy breathing together with 
response to anti-inflammatory maintenance therapy, bronchial hyperresponsiveness on methacholine challenge 
(PD20 < 0.6 mg) or bronchial obstruction reversible to β2-agonist (FEV1rev ≥ 12%). Food allergy was defined as 
symptoms of food allergy supported by either planned or accidental open food challenge. Allergic rhino-con-
junctivitis was defined as eye and/or nasal symptoms on exposure to pollen or animals together with a positive 
allergen-specific IgE test or skin prick test against a corresponding allergen.
Specific IgE was measured in venous blood against food (milk, egg, soy, fish, wheat and peanut; six-mix food 
test) and inhalant allergens (birch, timothy grass, mugwort, cat, dog, horse and house dust mite; Phadiatop), 
followed by specific IgE tests by ImmunoCAP (all from Phadia/Pharmacia Diagnostics, Uppsala, Sweden). 
An allergen-specific IgE level ≥ 0.35 kU/L was considered positive. Skin prick tests were performed in accord-
ance with European guidelines using standard allergen extracts (birch, grass, mugwort, cat, dog, horse, rabbit, 
Dermatophagoides pteronyssinus, Dermatophagoides farinae and Cladosporium (Soluprick SQ; ALK Abello AS, 
Hørsholm, Denmark), as previously  described20.
SCFA analysis. Fecal samples were collected at regular intervals by parents and transported in gas-tight 
sachets to the laboratory at Gothenburg University, where they were stored frozen at −  80  °C until further 
analysis. Samples obtained when the children were 4 weeks, 1 year and 3 years of age were selected for analysis 
of the concentration of acetic, propionic, iso-butyric, butyric, iso-valeric, valeric, iso-caproic and caproic acids 
by gas chromatography, using a method modified from Zhao et al.21. In brief, samples were thawed at room 
temperature, then the feces (200 mg) was mixed with water (1 mL) and homogenized for 20 s. The suspension 
was adjusted to pH 2–3 using dilute hydrochloric acid, kept at room temperature for 10 min, and centrifuged 
for 20 min at 5000 rpm. 180 μL of the supernatant was mixed with internal standard solution (20 μL; 7.9 mM 
2-ethylbutyric acid in 12% v/v aqueous formic acid). A gas chromatograph with flame ionization detector, fitted 
with a fused silica 30 m × 0.53 mm capillary column with free fatty acid stationary phase and with glass wool 
in the injection port liner, was used for analysis. The helium pressure was 30 kPa, injector temperature 200 °C, 
detector temperature 210  °C and injection volume 1  μL. The oven program was: 1  min at 100  °C, ramp to 
170 °C at 10 °C/min, ramp to 220 °C at 20 °C/min, 4 min at 220 °C. Peaks were identified using retention time. 
The SCFA:internal standard peak area ratio was determined for each SCFA peak, and the corresponding SCFA 
concentration determined from calibration curves. SCFA levels were not determined for 18 (28%) children at 
4 weeks, 1 (2%) at 1 year and 13 (20%) at 3 years of age, due to lack of material. Variables for analysis were the 
prevalence and concentration of each SCFA.
Dietary assessment. Data regarding the diet of the FARMFLORA children, including full details of the 
dietary assessment methodology, have been published  previously8,19. In brief, parents continuously recorded 
breastfeeding and formula practices, and introduction of new foods, in diaries up to 18 months of age. At 1 year 
of age (10–14 months), parents completed an unannounced 24-h dietary recall, followed by a 24-h food diary, of 
their children’s  diet8. The collected dietary information was registered and calculated based on the food compo-
sition database of the Swedish National Food Agency using the software Dietist Net Pro (Kost och Näringsdata, 
version 15.11.02, Stockholm, Sweden).
Statistical methods. The Mann–Whitney U test was used for the evaluation of differences in continuous 
variables between groups, as SCFA concentration and other variables were typically not normally distributed. 
For categorical variables the Chi-Squared test was used, or the Fisher’s Exact test for small samples. Friedman 
tests were used to compare the concentration of fecal SCFAs at different time points.
Multiple logistic regression was used to confirm associations between farm residence and SCFA levels after 
adjusting for covariates, and to identify explanatory variables. Dichotomous variables for high and low SCFA 
concentration were created. Variables that were associated with farm residence, and also predictive of SCFA 
level in univariate logistic regression analysis, (P ≤ 0.2 for both) were included as covariates. In addition, elder 
siblings and dietary intakes of protein and fibre were also included, as they have been linked theoretically with 
SCFA  levels9,18. Models were built using a backward conditional method.
Statistical analyses were performed with SPSS Statistics version 25 (IBM Corporation, New York, USA). 
Two-tailed P-values of < 0.05 were considered significant.
Results
Maturation of fecal SCFA pattern during early childhood in cohort children. We first examined 
how fecal SCFA patterns developed during early childhood, from 4 weeks to 3 years of age, among the cohort 
as a whole. There was considerable variation in both the prevalence and concentration of the various SCFAs 
between children at any given time. Nonetheless, a notable transition was observed in SCFA patterns over the 
first 3 years of life (Fig. 1).
Short chain fatty acids are made up of between two and six carbon atoms  (C2–C6), and may be straight-chain 
or branched (iso-, or i). At 4 weeks of age the shortest SCFA, acetic acid  (C2), was present in all infants with a 
median concentration of 86 μmol per gram of feces, and represented > 80% of the total SCFA concentration. 
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Propionic  (C3) and butyric  (C4) acids were each detected in at least 70% of infants, at much smaller median 
concentrations (6.1 and 1.9 μmol/g respectively, Fig. 1a). Iso-butyric (iC4) and iso-valeric (iC5) acids were also 
represented in up to 28% of infants, at concentrations up to 4 μmol/g. Finally, valeric  (C5), caproic  (C6) and/
or iso-caproic (iC6) acids were detected in a small minority of infants, at concentrations up to 9.8, 1.8 and 
1.7 μmol/g, respectively.
With age, the median total concentration of fecal SCFAs increased, from 104 μmol/g at 4 weeks of age to 
152 μmol/g at 3 years of age. By 3 years of age, acetic, propionic and butyric acids were present in all children, at 
median concentrations of 85, 32 and 28 μmol/g, respectively (Fig. 1a). Iso-butyric, iso-valeric and valeric acids 
were also detected in almost all children, although at much lower median concentrations (2–3 μmol/g; Fig. 1b: 
note different scale than in Fig. 1a). Further, caproic acid was detected in a third of children, at concentrations up 
to 2 μmol/g, while iso-caproic acid was detected in just one child in twenty, at concentrations up to 0.3 μmol/g.
Fecal SCFA patterns in farm and control children. At 4 weeks and 1 year of age, no significant differ-
ences were observed in the concentration of fecal SCFAs in children living on farms, compared to children living 
in the same rural area but not on farms (Table 2, Fig. 2a–c). However, at 3 years of age (Fig. 2d,e), children living 
on farms had higher median concentrations of several fecal SCFAs including iso-butyric (2.8 vs. 1.6 μmol/g, 
P = 0.03), iso-valeric (3.7 vs. 2.4 μmol/g, P = 0.03) and valeric acid (2.7 vs. 1.7 μmol/g, P = 0.01) than control 
children.
Association between life‑style factors and SCFA patterns. There were a number of differences in 
the demographic, family, birth and dietary characteristics of farm and rural control children (Table 1), many of 
which could influence gut microbiota composition. Multiple logistic regression models were used to determine 
whether living on a farm independently predicted the SCFA levels at 3 years of age significant in univariate 
analysis, after adjusting for covariates (Table 3). The models also enabled us to investigate factors that may help 
explain, and possibly mediate, the distinct SCFA profile seen in farm children, as well as identify factors that 
predicted SCFA levels in all children. Variables listed in Table 1 were screened for inclusion in the models. In 
addition, elder siblings and dietary intakes of protein and fibre were included as they have been linked previously 
with SCFA  levels9,18.
After adjustment, living on a farm continued to predict the concentrations of fecal iso-butyric, iso-valeric 
and valeric acids at 3 years of age (iso-butyric acid, aOR 17, 2.1–131, P = 0.008; iso-valeric acid, aOR 6.7, 1.5–30, 
P = 0.01; valeric acid, aOR 6.4, 1.4–31, P = 0.02). Further, having elder siblings predicted the concentration of 
fecal valeric acid independent of the farming effect (aOR 6.2; 95% CI 1.5–26; P = 0.01). Living with a cat or dog 
partly explained the higher concentration of fecal valeric acid in farm children, as indicated by a decrease in 
the principal odds ratio of 10% on addition of this variable to the logistic regression model (aOR 3.3; 95% CI 
0.8–13; P = 0.10).
Iso-butyric and iso-valeric acids are produced by microbial fermentation of the amino acids valine and 
 leucine10, and valeric acid is likewise generated from the amino acids proline and  hydroxyproline22. Using data 
from dietary registration at 1 year of age, we observed associations between dietary protein intake at 1 year of 
age and the concentration of fecal iso-butyric and iso-valeric acid at 3 years of age (aOR 1.3; 95% CI 1.1–1.5; 
P = 0.002 and aOR 1.1; 95% CI 1.0–1.3; P = 0.01, respectively), independent of farm residence. Dietary fibre intake 
at 1 year of age was negatively associated with the concentration of fecal iso-butyric and iso-valeric acid at 3 years 
of age (aOR 0.5; 95% CI 0.3–0.8; P = 0.003 and aOR 0.7; 95% CI 0.5–1.0; P = 0.04, respectively), independent of 
farm residence. No association was seen between protein or fibre intake and fecal valeric acid. Dietary intake 
Figure 1.  Development of fecal SCFA levels during early childhood. Median concentration of (a) total SCFAs 
and acetic, propionic and butyric acid, and (b) iso-butyric, iso-valeric and valeric acid, in children at 4 weeks 
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of homemade porridge at 1 year of age partly explained the higher concentration of iso-butyric acid in farm 
children (aOR 1.0; 95% CI 1.0–1.1; P = 0.08).
Links between SCFA levels and allergy development. We investigated whether fecal SCFAs at 
3 years of age were associated with eczema, asthma or allergic rhino-conjunctivitis at 8 years of age. No children 
had food allergy at 8 years of age. Of the 48 children who were clinically evaluated, nine had no fecal samples 
available. The analysis therefore included 39 children, nine of whom were allergic and 30 of whom had no allergy 
and were classified as non-allergic.
Children with eczema at 8 years of age had a lower median concentration of valeric acid in their feces at 
3 years of age than non-allergic children (0.5 vs. 2.3 μmol/g, P = 0.007; Fig. 3a). Other allergic manifestations 
could not be linked to valeric acid concentration (Fig. 3a), and concentrations of other SCFAs were not related 
to any allergy diagnosis at 8 years of age.
An analysis of only control children, to avoid possible confounding by farm residence, included just six 
allergic and 20 non-allergic children. Again, children who had eczema at 8 years of age had a lower median con-
centration of fecal valeric acid at 3 years of age than non-allergic children (0.5 vs. 1.5 μmol/g, P = 0.03; Fig. 3b).
An overview of key findings is presented in Fig. 4.
Discussion
Short chain fatty acids are end-products of fermentation of carbohydrate and protein by bacteria in the colon, 
and the pattern of individual SCFAs depends on microbiota composition, and also on the availability of substrates 
for fermentation. In early childhood, a gradual development of a more and more complex gut microbiota is seen, 
Table 2.  Prevalence and concentration of fecal SCFAs in farm and control children. *P < 0.05, Chi-squared or 
Fisher’s exact test for counts, Mann–Whitney U-test for continuous variables. ND, not detected. Feces analyzed 
from: a24 (86%) farm and 23 (62%) control children. b 28 (100%) farm and 36 (97%) control children. c 19 





Farm Control Farm Control
4 weeksa
Total SCFAs – – 109 (42–220) 103 (29–269)
Acetic 24 (100) 23 (100) 90 (34–177) 81 (20–259)
Propionic 17 (71) 18 (78) 5.0 (ND–63) 6.3 (ND–53)
Butyric 18 (75) 15 (65) 2.9 (ND–37) 1.1 (ND–30)
Iso-butyric 3 (13) 7 (30) ND (ND–4.1) ND (ND–4.0)
Iso-valeric 6 (25) 7 (30) ND (ND–3.8) ND (ND–4.4)
Valeric 4 (17) 1 (4) ND (ND–9.8) ND (ND–0.4)
Iso-caproic 3 (13) 1 (4) ND (ND–1.7) ND (ND–0.3)
Caproic 4 (17) 1 (4) ND (ND–1.8) ND (ND)
1 yearb
Total SCFAs – – 141 (57–359) 142 (82–253)
Acetic 28 (100) 36 (100) 87 (44–221) 92 (45–154)
Propionic 28 (100) 36 (100) 28 (3–48) 31 (8–87)
Butyric 28 (100) 36 (100) 25 (8–81) 20 (4–59)
Iso-butyric 22 (79) 29 (81) 1.5 (ND–4.8) 1.4 (ND–5.2)
Iso-valeric 27 (96) 35 (97) 2.2 (ND–7.6) 2.0 (0.2–6.9)
Valeric 24 (86) 27 (75) 0.3 (ND–4.8) 0.3 (ND–3.8)
Iso-caproic 5 (18) 7 (19) ND (ND–1.2) ND (ND–0.9)
Caproic 5 (18) 7 (19) ND (ND–0–3) ND (ND–0–3)
3 yearsc
Total SCFAs – – 157 (71–287) 152 (62–283)
Acetic 19 (100) 32 (100) 83 (46–163) 86 (32–133)
Propionic 19 (100) 32 (100) 33 (14–49) 30 (8–66)
Butyric 19 (100) 32 (100) 26 (6–94) 28 (7–70)
Iso-butyric 19 (100) 29 (91) 2.8* (ND–5.0) 1.6* (ND–5.3)
Iso-valeric 19 (100) 30 (94) 3.7* (1.3–7.6) 2.4* (ND–8.8)
Valeric 19 (100) 31 (97) 2.7* (0.4–6.2) 1.7* (ND–4.4)
Iso-caproic 0 (0) 3 (10) ND (ND) ND (ND–0.3)
Caproic 6 (32) 11 (34) ND (ND–1.9) ND (ND–1.3)
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from a rather simple composition in early infancy, with the successive establishment of more and more strict 
anaerobes leading to a pronounced dominance of anaerobic bacteria at 2 or 3 years of  age23.
Figure 2.  Fecal SCFA levels in farm and control children. Median concentration of total SCFAs and individual 
species of SCFAs in farm and rural control children at (a) 4 weeks, n = 24 (farm) and 23 (control); (b,c) 1 year, 
n = 28 (farm) and 36 (control), and (d,e) 3 years of age, n = 19 (farm) and 32 (control). Error bars show the 
interquartile range. *P < 0.05, Mann–Whitney U-test.
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In the early months, the major end points of metabolism of the gut microbes are acetic and lactic acid. Lactic 
acid is non-volatile and not detected by gas chromatography. Thus, acetic acid is by far the most abundant SCFA 
measured in the colon. The trends we observed in SCFA level from 4 weeks to 3 years of age, namely an early 
dominance of acetic acid  (C2) followed by the progressive increase in levels of the longer  (C3–5) and branched 
(iC4–5) SCFAs, are consistent with findings from a number of previous  studies18,24,25. In an adult-pattern micro-
flora containing hundreds of different  species26, different groups of bacteria species possess specific enzymes 
involved in the production of the various  SCFAs9. Indeed, the longest  (C5–6) and branched SCFAs are produced 
by anaerobes belonging to the dominant Bacteroidetes and Firmicutes phyla, often via cross-feeding  pathways27–29.
Iso-butyric and iso-valeric acids are produced via the microbial fermentation of the amino acids valine and 
 leucine10. Valeric acid is likewise generated from the amino acids proline and  hydroxyproline22, as well as by 
the microbial metabolism of  lactate30 and  propionate31. Accordingly, dietary protein intake at 1 year of age pre-
dicted levels of fecal iso-butyric and iso-valeric acid at 3 years of age. We have earlier reported quite pronounced 
Table 3.  Logistic regression models of demographic, family, birth and dietary characteristics on the 
associations between farm residence and high concentrations of fecal iso-butyric, iso-valeric and valeric 
acids at 3 years of age. *P < 0.05, binary logistic regression, n = 19 (farm) and 32 (control). a SCFA levels 
dichotomized as concentration of iso-butyric acid, > or ≤ 2.0 μmol/g; iso-valeric acid, > or ≤ 2.5 μmol/g; valeric 
acid, > or ≤ 2.0 μmol/g. b Final multivariate model. Additional variables related to farm residence and fecal SCFA 
concentration with P < 0.2, and therefore included in the model-building process, were: (iso-butyric acid) 
intake of homemade porridge and cream; (iso-valeric acid) cream; (valeric acid) father’s education level. Elder 
siblings and dietary intakes of protein and fibre were also included, as they have been linked theoretically with 
SCFA levels. c At 1 year of age. We hypothesized that intake at 1 year of age may well be similar to that at 3 years 
of age and/or may influence the development trajectory of the gut microbiota and short chain fatty acid profile. 
d,e The primary OR (d) increased or (e) decreased by ≥ 10% when the variable was removed and subsequently 
reintroduced into the model.
SCFAa Model type Predictor variable(s) OR (95% CI) P
Iso-butyric
Univariate Living on a farm 4.7 (1.3–16) 0.02*
Multivariateb
Living on a farm 17 (2.1–131) 0.008**
Protein (g/day)c,d 1.3 (1.1–1.5) 0.002**
Fibre (g/day)c,d 0.5 (0.3–0.8) 0.003**
Homemade porridge (g/day)c,e 1.0 (1.0–1.1) 0.08
Iso-valeric
Univariate Living on a farm 3.6 (1.0–12) 0.04*
Multivariateb
Living on a farm 6.7 (1.5–30) 0.01*
Protein (g/day)c,d 1.1 (1.0–1.3) 0.01*
Fibre (g/day)c,d 0.7 (0.5–1.0) 0.04*
Valeric
Univariate Living on a farm 6.9 (1.7–28) 0.008**
Multivariateb
Living on a farm 6.4 (1.4–31) 0.02*
Siblings 6.2 (1.5–26) 0.01*
Cat or  doge 3.3 (0.8–13) 0.10
Figure 3.  Fecal valeric acid levels at 3 years of age in relation to allergic manifestation at 8 years of age. In (a) 
the whole cohort (n = 39), including both farm and non-farm children, are shown, while (b) shows control 
children only (n = 26). Non-allergic children were defined as having no allergy at 8 years of age. *P < 0.05, 
**P < 0.01, Mann–Whitney U-test. Vertical bars show the median and inter-quartile range.
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differences in dietary pattern between farming and non-farming families in our cohort, regarding the maternal 
diet during  pregnancy32, fatty acid pattern in maternal  breastmilk32, and the children’s diet at 12 months of 
 age8, with intake of more full-fat dairy products and saturated fat in the farm mothers and children. However, 
protein intake did not vary between farm and control children in this study. Multiple logistic regression models 
confirmed that differences in diet and other factors we collected data on did not account for the increased levels 
of iso-butyric, iso-valeric and valeric acids observed at 3 years of age in farm children compared to controls in 
this study. Our results accordingly suggest that a more mature, complex gut microbiota in the farm children is 
the chief explanation for the increased levels of these SCFAs.
We observed substantially lower concentrations of fecal valeric acid at 3 years of age in children who had 
eczema at 8 years of age, as compared to non-allergic children. This relationship was evident in our entire cohort, 
and also in a sub-analysis of control children, indicating that high levels of fecal valeric acid derived from non-
farm exposures are also associated with protection from eczema, as discussed more fully below. However, levels of 
fecal valeric acid were higher in farm children than in non-allergic controls (median 2.7 vs. 1.5 μmol/g, P = 0.04), 
in line with the particularly strong degree of allergy protection conferred by growing up on a farm. We could not 
link valeric acid levels with allergic rhino-conjunctivitis or asthma, but these categories contained few children. 
Also, we did not find any association between the concentration of iso-butyric or iso-valeric acid at 3 years of 
age and any of the allergic conditions we assessed for at 8 years of age. Our findings suggest that farm-related 
protection from allergy may be mediated in part by fecal valeric acid, or by characteristics of the gut microbiota 
associated with fecal valeric acid.
To date, few other prospective studies have described fecal SCFA patterns in relation to subsequent allergy. 
However, consistent with our findings, Sandin et al. observed lower levels of fecal iso-butyric, iso-valeric and 
valeric acid at 1 year of age in children with reported food allergy at 4 years of age in the BarnAllergiStudie (BAS) 
birth cohort  study18. Further, data from the same birth cohort show lower levels of fecal valeric acid at 1 year of 
age in children with eczema, and also food allergy, at 13 years of age (Gio-Batta et al., Low levels of fecal valeric 
acid at 1 year of age are associated with eczema and food allergy at 13 years of age in a prospective birth cohort). 
Other prospective studies have generally not included valeric acid in the SCFA analysis. However, in another 
birth cohort, lower levels of fecal propionate and butyrate at 12 months of age were linked with higher risk of 
sensitization between 3 and 6 years of  age33. Further, in a clinical trial of non-digestible oligosaccharides in infant 
formula in high-risk infants, higher levels of fecal propionate and butyrate at 3 months of age, but lower levels 
of the same SCFAs at 6 months of age, were associated with eczema at 18 months34.
The pathogenesis of allergy has variously been related to impairment of epithelial barrier function, altered 
immune responses and dysbiosis of the gut  microbiota35–37. Recent studies demonstrate that valeric acid upregu-
lates tight junction proteins and also keratin (KRT1), promoting tissue integrity and barrier  function38,39. Con-
versely, KRT1-deficient mice show impaired skin barrier function and have a gene expression signature similar 
to that observed in skin of human eczema  patients40. Valeric acid also induces IL-10 production, inhibits IL-17 
and increases survival of regulatory B cells, thereby promoting the regulatory activity of  lymphocytes41,42. In 
addition, valeric acid is  antimicrobial43 and oral administration of valeric acid esters to rodents either fed a high 
fat diet or subjected to irradiation helps protect against gut  dysbiosis39,44. Further, administration of valeric acid 
or its esters to animal models protects against  colitis39 and necrotic  enteritis45, while adoptive transfer of valerate-
treated Bregs together with naive CD4 + T cells into Rag1-deficient mice protects against colitis and experimental 
autoimmune  encephalitis41. These studies suggest multiple mechanisms by which valeric acid may potentially 
protect against allergy, and show in-vivo efficacy of valeric acid against other immune-mediated diseases.
Besides farm residence and diet, some other factors also affected SCFA pattern. These included living with a 
cat or dog, which helped explain the increased fecal valeric acid levels in children raised on farms, as they were 
Figure 4.  Overview of key findings.
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more likely to own a pet than control children. Accordingly, data regarding the microbial composition of this 
cohort show a larger influence of cats and dogs on the gut microbiota than farm residence itself (Ljung et al., 
Effects of pets and farm residence on gut microbiota establishment and implications for allergy development). 
We also observed that children with older siblings had higher levels of fecal valeric acid, as was also noted by 
Sandin et al.18. Interestingly, infants with no older siblings tend to have an impoverished microbiota compared 
to infants with  siblings46. Both elder siblings and early pet exposure have also been associated with reduced risk 
of allergic  disease47,48.
The major limitation of this study was the moderate number of study subjects, yielding a limited number of 
allergic children. The strengths were the longitudinal design, permitting analysis of SCFA pattern development 
during early childhood and measurement of a broad range of dietary and other exposure data, as well as allergy 
being stringently diagnosed by study pediatricians. However, no environmental microbial samples were collected, 
and therefore the hypothesis that increased microbial exposure on farms may affect the structure and function 
of the gut microbiota could not be addressed directly.
In conclusion, growing up on a small dairy farm is associated with a fecal SCFA pattern suggestive of a more 
mature and complex anaerobic gut microbiota at 3 years of age, as compared to living in the surrounding rural 
area but not on a farm. Specifically, farm children had higher levels of fecal iso-butyric, iso-valeric and valeric 
acids. Diet could not explain this pattern, but exposure to pets accounted for part of the farming effect. High 
levels of fecal valeric acid were inversely associated with eczema at 8 years of age, suggesting that valeric acid may 
explain part of the farm-related protection from allergy. Although this finding needs to be confirmed in larger 
studies, it implies that valeric acid or microbes producing this metabolite could potentially offer therapeutic 
potential in preventing or treating eczema.
Data availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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